Golden Ten Data, December 10th, Dongbei Pharmaceutical announced that Jiangxi Fangda Iron and Steel Group Co., Ltd., a concerted action person of the controlling shareholder Fangda Group, plans to increase its shareholding of the company within 6 months from the date of the announcement, with a planned increase of not less than 75 million yuan and not exceeding 150 million yuan. Based on a reasonable judgment of the company's stock price and the overall trend of the capital market, Fangda Iron and Steel will seize the opportunity to implement the increase plan. The source of the increased funds is Fangda Iron and Steel's own funds and special loans.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Kuzeydoğu İlaç: Fangda Steel, hisse senetlerini 75 milyon ila 150 milyon arasında artırmayı planlıyor
Golden Ten Data, December 10th, Dongbei Pharmaceutical announced that Jiangxi Fangda Iron and Steel Group Co., Ltd., a concerted action person of the controlling shareholder Fangda Group, plans to increase its shareholding of the company within 6 months from the date of the announcement, with a planned increase of not less than 75 million yuan and not exceeding 150 million yuan. Based on a reasonable judgment of the company's stock price and the overall trend of the capital market, Fangda Iron and Steel will seize the opportunity to implement the increase plan. The source of the increased funds is Fangda Iron and Steel's own funds and special loans.